“Narcan encounters:” overdose and naloxone rescue experiences among people who use opioids

References

• Dyson T. Overdose deaths in US drop by 5 percent in 2018. UPI. https://www.upi.com/Health_News/2019/07/18/Overdose-deaths-in-US-drop-by-5-percent-in-2018/6121563458706/. Published: July 18, 2019. Accessed July 22, 2019.
   Google Scholar
• Ahmad FB, Escobedo LA, Rossen LM, Spencer MR, Warner M, Sutton P. Provisional Drug Overdose Death Counts. Hyattsville, MD: National Center for Health Statistics; 2019. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#dashboard. Accessed July 22, 2019.
   Google Scholar
• Rudd RA, Aleshire N, Zibbell JE, Matthew Gladden R. Increases in drug and opioid overdose deaths—United States, 2000–2014. Am J Transplant. 2016;16(4):1323–1327.
   Web of Science ®Google Scholar
• American Society of Addiction Medicine. Opioid Addiction 2016 Facts & Figures. North Bethesda, MD: American Society of Addiction Medicine; 2016. http://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf. Accessed December 23, 2016.
   Google Scholar
• Hedegaard H, Warner M, Miniño AM. Drug Overdose Deaths in the United States, 1999–2017. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2018.
   Google Scholar
• National Safety Council. Preventable deaths: odds of dying. https://injuryfacts.nsc.org/all-injuries/preventable-death-overview/odds-of-dying/data-details/. Accessed July 18, 2019.
   Google Scholar
• Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths – United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419–1427.
   PubMedGoogle Scholar
• Hedegaard H, Minino AM, Warner M. Drug overdose deaths in the United States, 1999–2017. NCHS Data Brief. 2018;(329):1–8.
   Google Scholar
• Gladden RM. Fentanyl law enforcement submissions and increases in synthetic opioid–involved overdose deaths—27 states, 2013–2014. MMWR Morb Mortal Wkly Rep. 2016;65:837–843.
   PubMed Web of Science ®Google Scholar
• Peterson AB. Increases in fentanyl-related overdose deaths—Florida and Ohio, 2013–2015. MMWR Morb Mortal Wkly Rep. 2016;65:844–849.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Davidson PJ, Iverson E, et al. “I felt like a superhero”: the experience of responding to drug overdose among individuals trained in overdose prevention. Int J Drug Policy. 2014;25(1):157–165.
   PubMed Web of Science ®Google Scholar
• Wheeler E, Jones TS, Gilbert MK, Davidson PJ; Centers for Disease Control and Prevention. Opioid overdose prevention programs providing naloxone to laypersons – United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(23):631–635.
   PubMed Web of Science ®Google Scholar
• Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abuse. 2015;36(2):240–253.
   PubMed Web of Science ®Google Scholar
• Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014;8(3):153–163.
   PubMed Web of Science ®Google Scholar
• Green BL, Miranda J, Daroowalla A, Siddique J. Trauma exposure, mental health functioning, and program needs of women in jail. Crime Delinquency. 2005;51(1):133–151.
   Web of Science ®Google Scholar
• Oliva EM, Nevedal A, Lewis ET, et al. Patient perspectives on an opioid overdose education and naloxone distribution program in the US Department of Veterans Affairs. Subst Abuse. 2016;37(1):118–126.
   PubMed Web of Science ®Google Scholar
• Hawk KF, Vaca FE, D’Onofrio G. Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies. Yale J Biol Med. 2015;88(3):235–245.
   PubMedGoogle Scholar
• Jordan MR, Naloxone DM. StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441910/. Updated February 2019.
   Google Scholar
• Wagner KD, Valente TW, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy. 2010;21(3):186–193.
   PubMed Web of Science ®Google Scholar
• McDonald R, Campbell ND, Strang J. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-conception and maturation. Drug Alcohol Depend. 2017;178:176–187.
   PubMed Web of Science ®Google Scholar
• McAuley A, Munro A, Taylor A. “Once I’d done it once it was like writing your name”: lived experience of take-home naloxone administration by people who inject drugs. Int J Drug Policy. 2018;58:46–54.
   PubMed Web of Science ®Google Scholar
• Lankenau SE, Wagner KD, Silva K, et al. Injection drug users trained by overdose prevention programs: responses to witnessed overdoses. J Community Health. 2013;38(1):133–141.
   PubMed Web of Science ®Google Scholar
• Richert T. Wasted, overdosed, or beyond saving–to act or not to act? Heroin users’ views, assessments, and responses to witnessed overdoses in Malmo, Sweden. Int J Drug Policy. 2015;26(1):92–99.
   PubMed Web of Science ®Google Scholar
• Sherman SG, Gann DS, Scott G, Carlberg S, Bigg D, Heimer R. A qualitative study of overdose responses among Chicago IDUs. Harm Reduct J. 2008;5(1):2.
   PubMed Web of Science ®Google Scholar
• Pollini RA, McCall L, Mehta SH, Celentano DD, Vlahov D, Strathdee SA. Response to overdose among injection drug users. Am J Prev Med. 2006;31(3):261–264.
   PubMed Web of Science ®Google Scholar
• Baca CT, Grant KJ. What heroin users tell us about overdose. J Addict Dis. 2007;26(4):63–68.
   PubMed Web of Science ®Google Scholar
• Baca CT, Grant KJ. Take-home naloxone to reduce heroin death. Addiction. 2005;100(12):1823–1831.
   PubMed Web of Science ®Google Scholar
• Heavey SC, Chang YP, Vest BM, Collins RL, Wieczorek W, Homish GG. ‘I have it just in case’ – Naloxone access and changes in opioid use behaviours. Int J Drug Policy. 2018;51:27–35.
   PubMed Web of Science ®Google Scholar
• Elliott L, Bennett AS, Wolfson-Stofko B. Life after opioid-involved overdose: survivor narratives and their implications for ER/ED interventions. Addiction. 2019;114(8):1379–1386.
   PubMed Web of Science ®Google Scholar
• Chang JS, Behar E, Coffin PO. Narratives of people who inject drugs on factors contributing to opioid overdose. Int J Drug Policy. 2019;74:26–32.
   PubMed Web of Science ®Google Scholar
• USCensus. QuickFacts: Erie County, New York. 2016. https://www.census.gov/quickfacts/table/RHI105210/36029
   Google Scholar
• Arditti JA. Situating vulnerability in research: implications for researcher transformation and methodological innovation. Qual Rep. 2015;20(10):1568–1575.
   Web of Science ®Google Scholar
• Benoit C, Jansson M, Millar A, Phillips R. Community-academic research on hard-to-reach populations: benefits and challenges. Qual Health Res. 2005;15(2):263–282.
   PubMed Web of Science ®Google Scholar
• Moore LW, Miller M. Initiating research with doubly vulnerable populations. J Adv Nurs. 1999;30(5):1034–1040.
   PubMed Web of Science ®Google Scholar
• Ellard-Gray A, Jeffrey NK, Choubak M, Crann SE. Finding the hidden participant solutions for recruiting hidden, hard-to-reach, and vulnerable populations. Int J Qual Methods. 2015;14(5): 1–10.
   Web of Science ®Google Scholar
• Burnard P, Gill P, Stewart K, Treasure E, Chadwick B. Analysing and presenting qualitative data. Br Dent J. 2008;204(8):429–432.
   PubMed Web of Science ®Google Scholar
• Charmaz K. Constructing Grounded Theory. 2nd ed. Los Angeles, CA: Sage; 2014.
   Google Scholar
• Bernard H. Research Methods in Anthropology: Qualitative and Quantitative Approaches. 4th ed. Lanham, MD: Altamira press; 2006.
   Google Scholar
• McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111(7):1177–1187.
   PubMed Web of Science ®Google Scholar
• Tobin K, Clyde C, Davey-Rothwell M, Latkin C. Awareness and access to naloxone necessary but not sufficient: examining gaps in the naloxone cascade. Int J Drug Policy. 2018;59:94–97.
   PubMed Web of Science ®Google Scholar
• Marshall C, Perreault M, Archambault L, Milton D. Experiences of peer-trainers in a take-home naloxone program: results from a qualitative study. Int J Drug Policy. 2017;41:19–28.
   PubMed Web of Science ®Google Scholar
• Doe-Simkins M, Quinn E, Xuan Z, et al. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health. 2014;14(1):297.
   PubMed Web of Science ®Google Scholar
• Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 2013;131(3):263–270.
   PubMed Web of Science ®Google Scholar
• Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007;14(7):616–623.
   PubMed Web of Science ®Google Scholar
• Mateu-Gelabert P, Jessell L, Goodbody E, et al. High enhancer, downer, withdrawal helper: multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City. Int J Drug Policy. 2017;46:17–27.
   PubMed Web of Science ®Google Scholar
• Frank D, Mateu-Gelabert P, Guarino H, et al. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users. Int J Drug Policy. 2015;26(1):84–91.
   PubMed Web of Science ®Google Scholar
• O’Halloran C, Cullen K, Njoroge J, et al. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland. Int J Drug Policy. 2017;46:34–40.
   PubMed Web of Science ®Google Scholar
• Schneider KE, Park JN, Allen ST, Weir BW, Sherman SG. Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: a latent class analysis. Drug Alcohol Depend. 2019;201:71–77.
   PubMed Web of Science ®Google Scholar
• Schuster JM, Loveland D, Parthasarathy M, Maiolo N, Cilia A, Castelnovo K. Reducing problematic benzodiazepine use among individuals enrolled in methadone treatment programs. J Addict Med. 2016;10(3):202–207.
   PubMed Web of Science ®Google Scholar
• Jann M, Kennedy WK, Lopez G. Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics. J Pharm Pract. 2014;27(1):5–16.
   PubMedGoogle Scholar
• Mateu-Gelabert P, Guarino H. Initiation of nonmedical prescription opioid use and development of opioid dependence among young adults. Drug Alcohol Depend. 2015;146:e196–e197.
   Google Scholar
• Stein MD, Kanabar M, Anderson BJ, Lembke A, Bailey GL. Reasons for benzodiazepine use among persons seeking opioid detoxification. J Subst Abuse Treat. 2016;68:57–61.
   PubMed Web of Science ®Google Scholar
• Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1–2):8–18.
   PubMed Web of Science ®Google Scholar
• Stein MD, Anderson BJ, Kenney SR, Bailey GL. Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder. J Subst Abuse Treat. 2017;77:67–71.
   PubMed Web of Science ®Google Scholar
• Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: a systematic review. Drug Alcohol Depend. 2019;200:95–114.
   PubMed Web of Science ®Google Scholar
• Latkin CA, Edwards C, Davey-Rothwell MA, Yang C, Tobin KE. The relationship between drug use settings, roles in the drug economy, and witnessing a drug overdose in Baltimore, Maryland. Subst Abuse. 2018;39(3):384–389.
   PubMed Web of Science ®Google Scholar
• Behar E, Chang JS, Countess K, Matheson T, Santos GM, Coffin P. Perceived causes of personal versus witnessed overdoses among people who inject opioids. Subst Use Misuse. 2019;54:1929–1937.
   PubMed Web of Science ®Google Scholar
• Erie County Department of Health. Erie County Department of Health announces trend in fentanyl-related overdose deaths. Erie County, New York. http://www2.erie.gov/health/index.php?q=press/erie-county-department-health-announces-trend-fentanyl-related-overdose-deaths. Accessed May 30, 2019.
   Google Scholar
• Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172–179.
   PubMed Web of Science ®Google Scholar
• Mars SG, Fessel JN, Bourgois P, Montero F, Karandinos G, Ciccarone D. Heroin-related overdose: the unexplored influences of markets, marketing and source-types in the United States. Soc Sci Med. 2015;140:44–53.
   PubMed Web of Science ®Google Scholar
• Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107–111.
   PubMed Web of Science ®Google Scholar
• Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183–188.
   PubMed Web of Science ®Google Scholar
• Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: exploring users’ perceptions of fentanyl-adulterated and substituted heroin. Int J Drug Policy. 2017;46:146–155.
   PubMed Web of Science ®Google Scholar
• Erie County Medical Examiner’s Office. Erie County Opioid Epidemic Update: Closed cases reported through 5/31/2019. 2019. Buffalo NY: Erie County Department of Health.
   Google Scholar
• Schiavon S, Hodgin K, Sellers A, et al. Medical, psychosocial, and treatment predictors of opioid overdose among high risk opioid users. Addict Behav. 2018;86:51–55.
   PubMed Web of Science ®Google Scholar
• Rowe C, Santos G-M, Behar E, Coffin PO. Correlates of overdose risk perception among illicit opioid users. Drug Alcohol Depend. 2016;159:234–239.
   PubMed Web of Science ®Google Scholar
• Martins SS, Sampson L, Cerda M, Galea S. Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature. Am J Public Health. 2015;105(11):2373–2373.
   PubMedGoogle Scholar
• Binswanger IA, Stern MF, Deyo RA, et al. Release from prison–a high risk of death for former inmates. N Engl J Med. 2007;356(2):157–165.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374(4):363–371.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689–1695.
   PubMed Web of Science ®Google Scholar
• Babu KM, Brent J, Juurlink DN. Prevention of opioid overdose. N Engl J Med. 2019;380(23):2246–2255.
   PubMed Web of Science ®Google Scholar
• Busch SH, Fiellin DA, Chawarski MC, et al. Cost-effectiveness of emergency department-initiated treatment for opioid dependence. Addiction. 2017;112(11):2002–2010.
   PubMed Web of Science ®Google Scholar
• D’Onofrio G, Chawarski MC, O’Connor PG, et al. Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention. J Gen Intern Med. 2017;32(6):660–666.
   PubMed Web of Science ®Google Scholar
• Dunkley CA, Carpenter JE, Murray BP, et al. Retrospective review of a novel approach to buprenorphine induction in the emergency department. J Emerg Med. 2019;57(2):181–186.
   PubMed Web of Science ®Google Scholar
• Scanlon S. Lifesaving opioid ER treatment born in Buffalo to go statewide. The Buffalo News. https://buffalonews.com/2019/07/24/life-saving-opioid-er-treatment-born-in-buffalo-to-go-statewide/. Accessed July 24, 2019.
   Google Scholar
• Watson DP, Brucker K, McGuire A, et al. Replication of an emergency department-based recovery coaching intervention and pilot testing of pragmatic trial protocols within the context of Indiana’s Opioid State Targeted Response plan. J Subst Abuse Treat. 2020;108:88–94.
   PubMed Web of Science ®Google Scholar
• McGuire AB, Powell KG, Treitler PC, et al. Emergency department-based peer support for opioid use disorder: emergent functions and forms. J Subst Abuse Treat. 2020;108:82–87.
   PubMed Web of Science ®Google Scholar
• Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA. 2002;288(15):1909–1914.
   PubMed Web of Science ®Google Scholar
• Prochaska JO, Norcross JC. Stages of change. Psychother Theory Res Pract Train. 2001;38(4):443–448.
   Web of Science ®Google Scholar
• Bohnert AS, Ilgen M. Understanding links among opioid use, overdose, and suicide. N Engl J Med. 2019;380(1):71–79.
   PubMed Web of Science ®Google Scholar
• Bohnert KM, Ilgen MA, Louzon S, McCarthy JF, Katz IR. Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration. Addiction. 2017;112(7):1193–1201.
   PubMed Web of Science ®Google Scholar
• Braden JB, Edlund MJ, Sullivan MD. Suicide deaths with opioid poisoning in the United States: 1999–2014. Am J Public Health. 2017;107(3):421–426.
   PubMed Web of Science ®Google Scholar
• Kelty E, Hulse G. Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone. Int J Drug Policy. 2017;46:54–60.
   PubMed Web of Science ®Google Scholar
• Oquendo MA, Volkow ND. Suicide: a silent contributor to opioid-overdose deaths. N Engl J Med. 2018;378(17):1567–1569.
   PubMed Web of Science ®Google Scholar
• Gaydosh L, Hummer RA, Hargrove TW, et al. The depths of despair among US Adults Entering Midlife. Am J Public Health. 2019;109(5):774–780.
   PubMed Web of Science ®Google Scholar
• Angell M. Opioid nation. NY Rev Books. 2018;LXV:56–58.
   Google Scholar